Enliven Therapeutics, Inc (ELVN) Misses Q4 EPS by 47c

March 14, 2024 5:40 PM

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.47).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.